PRESS RELEASE published on 11/17/2025 at 16:10, 5 months 21 days ago DigiKey to Highlight Innovative Automation Products and Industry-Leading Suppliers at SPS 2025 DigiKey showcases innovative automation products and top suppliers at SPS 2025, presenting a wide range of industrial automation solutions in Europe with interactive displays and expert insights Industrial Automation SPS 2025 DigiKey Automation Products Suppliers
PRESS RELEASE published on 11/17/2025 at 16:10, 5 months 21 days ago GPO Plus, Inc. Announces 20% Sequential Quarterly Revenue Growth and Accelerates Near-Term Expansion Initiatives GPO Plus, Inc. reports 20% revenue growth for Q2 2025, exceeding targets, expanding call center capacity, and accelerating store expansion with new product programs Revenue Growth Store Expansion GPO Plus Inc. Call Center Capacity New Product Programs
PRESS RELEASE published on 11/17/2025 at 16:05, 5 months 21 days ago SwitchBot Launches the New Presence Sensor with mmWave Radar SwitchBot officially launches the new Presence Sensor featuring mmWave radar for accurate room detection and smart automation, offering enhanced energy efficiency for homes Energy Efficiency Smart Home Automation SwitchBot Presence Sensor MmWave Radar
PRESS RELEASE published on 11/17/2025 at 15:37, 5 months 21 days ago Gold Terra is Upsizing Its Private Placement from C$6.3 Million to C$7.0 Million Gold Terra Resource Corp. announces oversubscription of non-brokered private placement with strong investor demand, total gross proceeds of C$7,000,000 and issuance of 55 million common shares and flow-through common shares Private Placement Flow-through Shares Investor Demand Gold Terra Yellowknife Project
PRESS RELEASE published on 11/17/2025 at 15:19, 5 months 21 days ago Original-Research: Lisata Therapeutics Inc (von First Berlin Equity Research GmbH): BUY First Berlin Equity Research updates Lisata Therapeutics Inc (ISIN: US1280583022) with a BUY rating and USD 15.00 price target. Results show operational improvement and positive data on certepetide platform First Berlin Equity Research BUY Rating Research Update Lisata Therapeutics Inc Certepetide Platform
PRESS RELEASE published on 11/17/2025 at 15:14, 5 months 21 days ago Amundi Physical Metals plc: Final Terms Amundi Physical Metals plc issues Final Terms for ETC Securities of Amundi Physical Gold ETC under Secured Precious Metal Linked ETC Securities Programme Gold ETC Amundi Physical Metals Plc ETC Securities Final Terms Secured Precious Metal
PRESS RELEASE published on 11/17/2025 at 15:08, 5 months 22 days ago Amundi Physical Metals plc: UK Final Terms Amundi Physical Metals plc issues ETC Securities of Amundi Physical Gold ETC under its Secured Precious Metal Linked ETC Securities Programme. Details include Metal Entitlement and Issue Date Gold ETC Amundi Physical Metals Plc ETC Securities Precious Metal Tranche Issue
PRESS RELEASE published on 11/17/2025 at 14:32, 5 months 22 days ago Original-Research: Deutsche Effecten- und Wechsel- Beteiligungsgesellschaft AG (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research updates recommendation on Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft AG to Buy with a target price of EUR 1.10. Analysis includes H1 2025 results and future outlook First Berlin Equity Research Buy Recommendation Research Update Deutsche Effecten- Und Wechsel-Beteiligungsgesellschaft AG EUR 1.10 Target Price
PRESS RELEASE published on 11/17/2025 at 14:30, 5 months 22 days ago Kidoz Inc. to Publish Q3 2025 Financial Results on Thursday November 20th, 2025 Kidoz Inc. to publish Q3 earnings on ACCESS Newswire & websites. Annual General Meeting on Nov 25, 2025, in Vancouver & online. AdTech platform for safe mobile gamer engagement Annual General Meeting Kidoz Inc. Q3 Earnings AdTech Platform Mobile Gamer Engagement
PRESS RELEASE published on 11/17/2025 at 14:30, 5 months 22 days ago NanoViricides, Inc. Has Filed its Quarterly Report - Subsequent Raise Has Fortified Fiscal Position NanoViricides, Inc. files Form 10-Q for Q3 2025 with SEC, presents NV-387 as broad-spectrum antiviral drug addressing unmet medical needs. Company strengthens financial position with recent financings NanoViricides NV-387 Financings Form 10-Q Antiviral Drug
Published on 05/09/2026 at 01:30, 13 hours 41 minutes ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 15 hours 11 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 20:38, 18 hours 33 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 19 hours 58 minutes ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 20 hours 9 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 19 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:06, 1 day 20 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 18:17, 1 day 20 hours ago DESCRIPTION OF THE LOUIS HACHETTE GROUP SHARE BUYBACK PROGRAM 2026-2027
Published on 05/07/2026 at 17:45, 1 day 21 hours ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL